Home › Products › Oncology › Leuprosun 11.25mg Injection
Leuprosun 11.25mg Injection
Salt Composition: LEUPROLIDE ACETATE
- Manufacturer: SUNLIGHT LIFESCIENCE
- Pack Size: 1 VIAL(s) OF 2ML
- Dosage Form: INJECTION
- Strength: 11.25MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Keep Leuprosun 11.25mg Injection out of sight and reach of children. Store in a cool, dry place, away from direct heat and light. Store below 25oC Do not refrigerate or freeze.
₹5110.00₹8625.00
Inclusive of all taxes
Product Introduction
Leuprosun 11.25mg Injection contains the active ingredient leuprolide acetate. It is a Gonadotropin Releasing Hormone (GnRH) agonist. Leuprosun 11.25mg is indicated for prostate cancer in men, hormone-responsive breast cancer, and endometriosis (tissue that normally lines the interior of the uterus growing outside it) and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used to treat central precocious puberty (premature puberty); a condition in which certain hormonal releases cause a child's body to develop into an adult form at an early age. Do not use this medicine if you are allergic to leuprolide acetate or any other ingredients, including Goserelin and Triptorelin. Before receiving this medicine, inform your doctor if you have liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not use this medicine if you are pregnant or planning to become pregnant. During treatment, existing symptoms may worsen due to increased sex steroid levels in the body. Discuss any concerns with your doctor. Report to your doctor if your child has a progressive brain tumour. Before starting treatment, notify your doctor of underlying medical conditions such as diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or increased risk of bone thinning (osteoporosis). This medicine is not recommended in pregnant and breastfeeding women and patients with abnormal vaginal bleeding. If you are a woman of childbearing potential, use non-hormonal contraceptives during treatment with Leuprosun 11.25mg Injection. Report to your doctor if you are a man with urinary obstruction or have undergone testicle removal. Inform your doctor if you experience spinal cord pressure, urinary disorders, or haematuria (blood in the urine).
Uses
Leuprosun 11.25mg Injection uses: Prostate cancer Hormone-responsive breast cancer in perimenopausal (around menopause) women Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones)
How it works
Leuprosun 11.25mg Injection decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.
Side Effects
Leuprosun 11.25mg side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Severe rash, itching Shortness or difficulty of breath Cough with blood Pulmonary embolism Severe headache Common Altered blood sugar and cholesterol levels Injection site reactions Loss of appetite Abnormal liver function Swelling in ankle or hand Difficulty sleeping, headache Mood swings, depression Weight changes Nausea, vomiting Vaginal dryness, bleeding Loss of interest in sexual intercourse Hot flushes Bone pain, muscle weakness Breast tenderness
References
- 1.Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Introduction to Endocrinology: The hypothalamic-pituitary axis, 12th edition, 2011, 1122. 2.KD Tripathi, Essentials of Medical Pharmacology, Anterior pituitary hormones, 7th edition, 2013, 243. 3.Takeda UK Limited, Electronic medicines compendium (emc), [Revised on June 2022] [ Accessed on 12th April 2023], https://www.medicines.org.uk/emc/product/4651/smpc 4.Abbott Laboratories, US Food and Drug Administration, [Issued on Feb 2016] [ Accessed on 12th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020517s036_019732s041lbl.pdf
Safety Advice
Pregnancy: unsafe It is unsafe to use Leuprosun 11.25mg Injection because it is contraindicated in pregnant women. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.
Lungs: Consult your doctor Inform your doctor if you experience any pulmonary embolism, shortness or difficulty of breath, or other underlying lung conditions before taking the Leuprosun 11.25mg Injection, Consult your doctor for more information.
Breastfeeding: unsafe Leuprosun 11.25mg Injection is contraindicated in breastfeeding women. Inform your doctor if you are breastfeeding before taking this injection.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.